Financials

  • Market Capitalization 215.14 M
  • Employee 87
  • Founded 2015
  • CEO N/A
  • Website www.kerostx.com
  • Headquarter Massachusetts, United States
  • FIGI BBG00H1HP9G9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.36
ratio cours/chiffre d'affaires
13.69

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3575
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
3.68 USD-0.27%-6.36%-8.00%+25.17%220.36 M USD
3579
KPTI
Karyopharm Therapeutics Inc. - Common Stock
9.62 USD-3.90%-9.59%-0.21%-0.21%218.02 M USD
3587
SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares
76.95 USD+2.07%+3.73%+5.40%+863.08%214.39 M USD
3590
NBP
NovaBridge Biosciences - American Depositary Shares
1.85 USD+2.78%-4.64%+14.91%-58.98%213.46 M USD

Nouvelles